An interventional study of Carbon Fiber Custom Dynamic Orthosis in Healthy, sponsored by Jason Wilken. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by Jason Wilken · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Carbon fiber custom dynamic orthoses (CDOs) include a full-length footplate, a stiff posterior spring, and a cuff that wraps around the leg below the knee. CDOs restore function after limb trauma, decrease forefoot loading, and reduce pain. However, initial introduction to a CDO is not consistent, so this study is being conducted to determine if different methods of training alter forefoot loading during gait. Unimpaired adult participants will be randomized to one of three groups: 1) no feedback, 2) visual feedback of forefoot force, and 3) visual feedback of cuff forces. All participants will walk at a controlled speed on a treadmill without the CDO, after initial introduction to the CDO, and after completing two rounds of training in the CDO.
Carbon fiber custom dynamic orthoses (CDOs) restore function for individuals with limb trauma. CDOs include a full-length footplate, a stiff posterior spring, and a proximal cuff that wraps around the leg below the knee. A key benefit of CDOs is the ability to decrease forefoot loading, which may reduce pain during walking. However, initial introduction to a CDO is not consistent and some individuals struggle to relax their lower leg muscles and rely on the CDO for support, reducing the potential offloading benefits of the CDO and increasing the risk of abandoning the CDO.
In this study we will investigate different methods of training, with or without visual feedback, to determine if training method alters forefoot loading during walking. Unimpaired adult participants will be randomized to one of three groups: 1) no feedback, 2) visual feedback of forefoot force, and 3) visual feedback of cuff forces. All participants will walk at a controlled speed on a treadmill without the CDO, after initial introduction to the CDO, and after completing two rounds of training in the CDO. Participants will complete questionnaires regarding pain and perceived CDO comfort and smoothness. Force within the CDO cuff and footplate will be measured using wireless force measuring sensors (Loadsol/Loadpad, Novel Electronics).
Jason Wilken is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will walk in the study CDO without visual feedback of limb loading during gait.
Device: Carbon Fiber Custom Dynamic Orthosis
Participants will walk in the study CDO while being provided visual feedback of forefoot loading loading during gait. Forefoot loading will be measured using wireless insoles placed in the CDO footplate.
Device: Carbon Fiber Custom Dynamic Orthosis
Participants will walk in the study CDO while being provided visual feedback of cuff loading loading during gait. Cuff loading will be measured using wireless insoles placed in the CDO proximal cuff.
Device: Carbon Fiber Custom Dynamic Orthosis
Participants will walk without a CDO.
The carbon fiber custom dynamic orthosis (CDO) used in this study will consist of a semi-rigid carbon fiber footplate, a carbon fiber posterior strut, and a proximal cuff that wraps around the leg below the knee.
Also known as: Ankle Foot Orthosis
Peak Forefoot Force
Peak plantar forces, normalized to body mass (N/kg) will be measured across the forefoot (distal 40% of sensor).
Time frame: Baseline
Forefoot Force Impulse
Plantar force impulse, normalized to body mass (Ns/kg) across the forefoot (distal 40% of sensor) will be calculated using the integral of the force over the stance phase.
Time frame: Baseline
Peak Midfoot Force
Peak plantar forces, normalized to body mass (N/kg) will be measured across the midfoot (middle 30% of sensor).
Time frame: Baseline
Midfoot Force Impulse
Plantar force impulse, normalized to body mass (Ns/kg) across the midfoot (middle 30% of sensor) will be calculated using the integral of the force over the stance phase.
Time frame: Baseline
Peak Hindfoot Force
Peak plantar forces, normalized to body mass (N/kg) will be measured across the hindfoot (proximal 30% of sensor).
Time frame: Baseline
Hindfoot Force Impulse
Plantar force impulse, normalized to body mass (Ns/kg) across the hindfoot (proximal 30% of sensor) will be calculated using the integral of the force over the stance phase.
Time frame: Baseline
Peak Total Foot Force
Peak plantar forces, normalized to body mass (N/kg) will be measured across the total foot (100% of sensor).
Time frame: Baseline
Total Foot Force Impulse
Plantar force impulse, normalized to body mass (Ns/kg) across the total foot (100% of sensor) will be calculated using the integral of the force over the stance phase.
Time frame: Baseline
Numerical Pain Rating Scale
Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable
Time frame: Baseline
Modified Socket Comfort Score (Comfort)
Comfort scores range from 0 = most uncomfortable to 10= most comfortable
Time frame: Baseline
Modified Socket Comfort Score (Smoothness)
Smoothness scores range from 0 = least smooth to 10 = most smooth
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jason Wilken